Immunotherapy for metastatic renal cell carcinoma: A systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy for metastatic renal cell carcinoma: A systematic review

Published:2019-08-20 Issue:4 Volume:12 Page:253-262
ISSN:1756-5383
Container-title:Journal of Evidence-Based Medicine
language:en
Short-container-title:J Evid Based Med.

Author:

Peinemann Frank¹²,Unverzagt Susanne³,Hadjinicolaou Andreas V⁴,Moldenhauer Ines⁵

Affiliation:

1. Pediatric Oncology and Hematology, Children's Hospital University Hospital of Cologne Cologne Germany

2. FOM University of Applied Science for Economics & Management Essen Germany

3. Institute of Medical Epidemiology, Biostatistics, and Informatics University Hospital Halle Halle (Saale) Germany

4. Human Immunology Unit, Institute of Molecular Medicine, Radcliffe Department of Medicine Oxford University Oxford UK

5. Department of Internal Medicine I University Hospital Halle Halle (Saale) Germany

Publisher

Wiley

Subject

Health Policy,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jebm.12362

Reference65 articles.

1. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. EAU Guidelines on Renal Cell Carcinoma: 2014 Update

3. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review;Frontiers in Immunology;2024-07-10

2. A novel prognostic predictor of immune microenvironment and therapeutic response in clear cell renal cell carcinoma based on angiogenesis–immune-related gene signature;Heliyon;2024-01

3. Targeting CTLA-4 in Cancer: Biological Insights with a Focus on Renal Cell Carcinoma;annals of urologic oncology;2022-12-20

4. Inflammatory Prognostic Index in Metastatic Renal Carcinoma Treated with Nivolumab;Journal of the College of Physicians and Surgeons Pakistan;2022-10-01

5. Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy;Frontiers in Immunology;2022-09-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3